Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

Qingxin Jiaotai Decoction

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · PHASE EARLY PHASE 1 TRIAL

Qing-Xin-Jiao-Tai Decoction for Insomnia Comorbid With Obesity Presenting With Heart-Kidney Non-interaction Syndrome

ClinicalTrials.gov

This is an early-phase (Phase 1) registered trial not yet recruiting with no results posted; it describes a planned study design and endpoints but carries no outcome data.

PreliminaryObesity Qingxin Jiaotai Decoction NCT07754383

Reported

Planned sample size72

PhaseEarly Phase 1

Study duration (active interventi…8 weeks

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support